Allscripts Healthcare Solution Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 7/22/2026)
| Balance Sheet | Total Assets | 1,352,287,000.00 | ROE | – |
| Balance Sheet | Total Equity | 803,988,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -1,552,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | -21,577,000.00 | – | – |
| Cashflow | Operating Cash Flow | -20,025,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 0.18 | Div. Yield | – |
| Income | Net Income | -291,542,000.00 | P/E | – |
| Income | Shares Outstanding | 128,900,000.00 | P/B | – |
| Income | Total Revenue | 594,410,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Allscripts Healthcare Solutions, Inc. delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. Its Population Health segment includes sale of health management and coordinated care solutions that are focused on hospitals, health systems, other care facilities and accountable care organizations. These solutions enable clients to connect, transition, analyze, and coordinate care across the care community.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.allscripts.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more